PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pharming Group N.V.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026
$9.11−0.25 (-2.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 2277.5
- Dividend yield
- –
Dividends
Pharming has not reported a dividend
No dividend per share appears in Pharming's annual filings since fiscal 2018.